Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (19135)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Aug 7, 2017 (publication date) through Nov 3, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Dimitroulis D, Damaskos C, Valsami S, Davakis S, Garmpis N, Spartalis E, Athanasiou A, Moris D, Sakellariou S, Kykalos S, Tsourouflis G, Garmpi A, Delladetsima I, Kontzoglou K, Kouraklis G. From diagnosis to treatment of hepatocellular carcinoma: An epidemic problem for both developed and developing world. World J Gastroenterol 2017; 23(29): 5282-5294 [PMID: 28839428 DOI: 10.3748/wjg.v23.i29.5282] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v23/i29/5282.htm |
| Number | Citing Articles |
| 1 |
Ezio Lanza, Chiara Masetti, Gaia Messana, Riccardo Muglia, Nicola Pugliese, Roberto Ceriani, Ana Lleo de Nalda, Lorenza Rimassa, Guido Torzilli, Dario Poretti, Felice D’Antuono, Letterio Salvatore Politi, Vittorio Pedicini, Alessio Aghemo, Gianfranco D. Alpini. Sarcopenia as a predictor of survival in patients undergoing bland transarterial embolization for unresectable hepatocellular carcinoma. PLOS ONE 2020; 15(6): e0232371 doi: 10.1371/journal.pone.0232371
|
| 2 |
Tommaso Vincenzo Bartolotta, Adele Taibbi, Massimo Midiri, Roberto Lagalla. Contrast-enhanced ultrasound of hepatocellular carcinoma: where do we stand?. Ultrasonography 2019; 38(3): 200 doi: 10.14366/usg.18060
|
| 3 |
Tsinat Berhane, Anja Holm, Kasper Thystrup Karstensen, Andreas Petri, Mirolyuba Simeonova Ilieva, Henrik Krarup, Mogens Vyberg, Marianne Bengtson Løvendorf, Sakari Kauppinen. Knockdown of the long noncoding RNA PURPL induces apoptosis and sensitizes liver cancer cells to doxorubicin. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-23802-9
|
| 4 |
Yongxian Cao, Feng Zhang, Haotian Wang, Chunhua Bi, Jinpeng Cui, Fenghai Liu, Huazheng Pan. LncRNA MALAT1 mediates doxorubicin resistance of hepatocellular carcinoma by regulating miR-3129-5p/Nova1 axis. Molecular and Cellular Biochemistry 2021; 476(1): 279 doi: 10.1007/s11010-020-03904-6
|
| 5 |
Maryam Sadat Abtahi, Alireza Fotouhi, Niloufar Rezaei, Hilal Akalin, Yusuf Ozkul, Nikoo Hossein-Khannazer, Massoud Vosough. Nano-based drug delivery systems in hepatocellular carcinoma. Journal of Drug Targeting 2024; 32(9): 977 doi: 10.1080/1061186X.2024.2365937
|
| 6 |
Melroy Alistair D’Souza, Mahesh Goel, Shraddha Patkar. Tata Memorial Centre Textbook of Oncology. 2024; : 535 doi: 10.1007/978-981-99-3378-5_38
|
| 7 |
Aimei Liu, Qinghua Wu, Dapeng Peng, Irma Ares, Arturo Anadón, Bernardo Lopez‐Torres, María‐Rosa Martínez‐Larrañaga, Xu Wang, María‐Aránzazu Martínez. A novel strategy for the diagnosis, prognosis, treatment, and chemoresistance of hepatocellular carcinoma: DNA methylation. Medicinal Research Reviews 2020; 40(5): 1973 doi: 10.1002/med.21696
|
| 8 |
Ludovico Abenavoli, Angelo A. Izzo, Natasa Milić, Carla Cicala, Antonello Santini, Raffaele Capasso. Milk thistle (Silybum marianum): A concise overview on its chemistry, pharmacological, and nutraceutical uses in liver diseases. Phytotherapy Research 2018; 32(11): 2202 doi: 10.1002/ptr.6171
|
| 9 |
Areeg M. Dabbish, Hana M. Abdelzaher, Moustafa Abohawya, Samir Shamma, Yosra H. Mahmoud, Amr Maged, Mohamed Manaa, Mohamed Hassany, Firas Kobeissy, Omid Bazgir, Hassan El-Fawal, Hassan M. E. Azzazy, Anwar Abdelnaser. Prognostic MicroRNA Panel for HCV-Associated HCC: Integrating Computational Biology and Clinical Validation. Cancers 2022; 14(13): 3036 doi: 10.3390/cancers14133036
|
| 10 |
Fengxia Zeng, Hui Dai, Xu Li, Le Guo, Ningyang Jia, Jun Yang, Danping Huang, Hui Zeng, Weiguo Chen, Ling Zhang, Genggeng Qin. Preoperative radiomics model using gadobenate dimeglumine-enhanced magnetic resonance imaging for predicting β-catenin mutation in patients with hepatocellular carcinoma: A retrospective study. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.916126
|
| 11 |
_ _, Oszkár Hahn, Attila Szijártó, Damján Pekli, András Fülöp, Bálint Kokas, Dávid Bárdos, Csilla András, Péter Bartek, István Battyáni, János Bezsilla, György Bodoky, Attila Bursics, Magdolna Dank, Zsófia Dankovics, Ákos Deák Pál, Kristóf Dede, Gyula Demeter, Attila Doros, Ibolyka Dudás, Zsófia Egyed, Róbert Farkas, Zsuzsanna Gerlei, Tamás Györke, Krisztina Hagymási, Oszkár Hahn, Erika Hitre, József Hőhn, Viktor Jancsik, Zsolt Káposztás, István Király, András Kiss, László Kóbori, Péter Kupcsulik, Gábor Lakatos, István Lázár, Tamás Lóderer, Endre Nagy, Attila Oláh, Péter Pajor, András Papp, Gabriella Pár, Mihály Patyánik, Damján Pekli, Ágota Petrányi, András Petri, László Piros, János Schuller, László Sikorszki, József Szabó, Eszter Székely, Attila Szijártó, Andrea Szombati, László Torday, Judit Tóth, Lajos Barna Tóth, Edit Dósa, László Harsányi, Zsolt Horváth, Gábor István, László Landherr, György Lázár, Gabriella Lengyel, József Lővey, László Mangel, Pál Maurovich Horváth, Balázs Nemes, András Palkó, Zsuzsa Schaff, Ferenc Szalay, Ákos Szűcs, András Vereczkei. A hepatocellularis carcinoma komplex kezelése.. Orvosi Hetilap 2022; 162(Supplement-2): 2 doi: 10.1556/650.2021.32431
|
| 12 |
Wafaa M. Rashed, Mohamed Ahmed Mohamed Kandeil, Mohamed O. Mahmoud, Sameera Ezzat. Hepatocellular Carcinoma (HCC) in Egypt: A comprehensive overview. Journal of the Egyptian National Cancer Institute 2020; 32(1) doi: 10.1186/s43046-020-0016-x
|
| 13 |
Ibrahim G Alghamdi, Mohamed S Alghamdi. <p>The Incidence Rate of Liver Cancer in Saudi Arabia: An Observational Descriptive Epidemiological Analysis of Data from the Saudi Cancer Registry (2004–2014)</p>. Cancer Management and Research 2020; : 1101 doi: 10.2147/CMAR.S232600
|
| 14 |
Ismail Essadi, Issam Lalya, Mohamed Kaakoua, Adil Arsalane, Abdelhamid Elomrani, Mouna Khouchani, Rhizlane Belbaraka. Skull metastases revealing a hepatocellular carcinoma: Case report and literature review. Precision Medical Sciences 2020; 9(2): 94 doi: 10.1002/prm2.12011
|
| 15 |
Otilia Mårdh, Chantal Quinten, Andrew J. Amato-Gauci, Erika Duffell. Mortality from liver diseases attributable to hepatitis B and C in the EU/EEA – descriptive analysis and estimation of 2015 baseline. Infectious Diseases 2020; 52(9): 625 doi: 10.1080/23744235.2020.1766104
|
| 16 |
Liping Zuo, Shuo Shi, Jinlei Fan, Ziyu Tian, Dexin Yu. MRI-based preoperative markers combined with narrow-margin hepatectomy result in higher early recurrence. European Journal of Radiology 2022; 157: 110521 doi: 10.1016/j.ejrad.2022.110521
|
| 17 |
Shuoshuo Ma, Fangfang Chen, Chuanle Lin, Wanliang Sun, Dongdong Wang, Shuo Zhou, ShiRu Chang, Zheng Lu, Dengyong Zhang. MiR-186-5p prevents hepatocellular carcinoma progression by targeting methyltransferase-like 3 that regulates m6A-mediated stabilization of follistatin-like 5. Heliyon 2024; 10(5): e26767 doi: 10.1016/j.heliyon.2024.e26767
|
| 18 |
Patrizia Leone, Antonio Giovanni Solimando, Rossella Fasano, Antonella Argentiero, Eleonora Malerba, Alessio Buonavoglia, Luigi Giovanni Lupo, Valli De Re, Nicola Silvestris, Vito Racanelli. The Evolving Role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Treatment. Vaccines 2021; 9(5): 532 doi: 10.3390/vaccines9050532
|
| 19 |
Yu Zhong, Hong Huo, Shuqi Dai, Su Li. Efficacy and safety of immune checkpoint inhibitors-combined antiangiogenic drugs in the treatment of hepatocellular carcinoma: A systematic review and meta analysis. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.964779
|
| 20 |
Asmaa M. Zahran, Hanaa Nafady-Hego, Shima G. Mansor, Wael A. Abbas, Mohamed O. Abdel-Malek, Mohamed A. Mekky, Helal F. Hetta. Increased frequency and FOXP3 expression of human CD8+CD25High+ T lymphocytes and its relation to CD4 regulatory T cells in patients with hepatocellular carcinoma. Human Immunology 2019; 80(7): 510 doi: 10.1016/j.humimm.2019.03.014
|
| 21 |
Dow-Mu Koh, Ahmed Ba-Ssalamah, Giuseppe Brancatelli, Ghaneh Fananapazir, M. Isabel Fiel, Satoshi Goshima, Sheng-Hong Ju, Nikolaos Kartalis, Masatoshi Kudo, Jeong Min Lee, Takamichi Murakami, Max Seidensticker, Claude B. Sirlin, Cher Heng Tan, Jin Wang, Jeong Hee Yoon, Mengsu Zeng, Jian Zhou, Bachir Taouli. Consensus report from the 9th International Forum for Liver Magnetic Resonance Imaging: applications of gadoxetic acid-enhanced imaging. European Radiology 2021; 31(8): 5615 doi: 10.1007/s00330-020-07637-4
|
| 22 |
Samer Jumean, Shatha Elemian, Hamid S Shaaban, Gunwant Guron. Skull Metastasis With Orbital Invasion as a Primary Manifestation of Hepatocellular Carcinoma. Cureus 2024; doi: 10.7759/cureus.55091
|
| 23 |
Anh Le Tuan Nguyen, Hoa Thi Thu Nguyen, Kwang Chien Yee, Andrew J. Palmer, Christopher Leigh Blizzard, Barbara de Graaff. A Systematic Review and Narrative Synthesis of Health Economic Evaluations of Hepatocellular Carcinoma Screening Strategies. Value in Health 2021; 24(5): 733 doi: 10.1016/j.jval.2020.11.014
|
| 24 |
Zhipeng Sun, Guangyang Chen, Liang Wang, Qing Sang, Guangzhong Xu, Nengwei Zhang. APEX1 promotes the oncogenicity of hepatocellular carcinoma via regulation of MAP2K6. Aging 2022; 14(19): 7959 doi: 10.18632/aging.204325
|
| 25 |
Mohamed Fawzi Kabil, Osama A. Badary, Frank Bier, Shaker A. Mousa, Ibrahim M. El-Sherbiny. A comprehensive review on lipid nanocarrier systems for cancer treatment: fabrication, future prospects and clinical trials. Journal of Liposome Research 2023; : 1 doi: 10.1080/08982104.2023.2204372
|
| 26 |
Justin K. H. Liu, Andrew F. Irvine, Rebecca L. Jones, Adel Samson. Immunotherapies for hepatocellular carcinoma. Cancer Medicine 2022; 11(3): 571 doi: 10.1002/cam4.4468
|
| 27 |
Yue Liu, Huasong Xia, Meng Li, Yuxin Chen, Wei Zhou, Yi Chen, Yanqing Wu, Liaqat Ali. Overexpressed RING Finger 44 Correlates with Poor Prognosis in Hepatocellular Carcinoma. Journal of Healthcare Engineering 2022; 2022: 1 doi: 10.1155/2022/3522866
|
| 28 |
Ion Agirrezabal, Luiz Sérgio Pereira Grillo Junior, Felipe Nasser, Victoria K. Brennan, Diogo Bugano, Francisco Leonardo Galastri, André Luis F. de Azeredo- da-Silva, Suki Shergill, Joaquim Maurício da Motta-Leal-Filho. Cost-effectiveness of selective internal radiation therapy with Y-90 resin microspheres for intermediate- and advanced-stage hepatocellular carcinoma in Brazil. Journal of Medical Economics 2023; 26(1): 731 doi: 10.1080/13696998.2023.2210475
|
| 29 |
Zhiying Shao, Xin Liu, Chanjuan Peng, Liping Wang, Dong Xu. Combination of transcatheter arterial chemoembolization and portal vein embolization for patients with hepatocellular carcinoma: a review. World Journal of Surgical Oncology 2021; 19(1) doi: 10.1186/s12957-021-02401-4
|
| 30 |
Chunhua Liu, Simin Wu, Liying Lai, Jinyu Liu, Zhaofu Guo, Zegen Ye, Xiang Chen. Comprehensive analysis of cuproptosis-related lncRNAs in immune infiltration and prognosis in hepatocellular carcinoma. BMC Bioinformatics 2023; 24(1) doi: 10.1186/s12859-022-05091-1
|
| 31 |
Sahabjada Siddiqui, Rumana Ahmad, Mohsin Ali Khan, Shivbrat Upadhyay, Ishrat Husain, Anand Narain Srivastava. Cytostatic and Anti-tumor Potential of Ajwa Date Pulp against Human Hepatocellular Carcinoma HepG2 Cells. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-018-36475-0
|
| 32 |
Chun-Ying Yan, Zuo-Jun Fu, Gui-Sheng Liu, Jiang Li, Chen-Xi Sun. Value of heat shock protein 90 combined with alpha-fetoprotein in early diagnosis of hepatocellular carcinoma. World Chinese Journal of Digestology 2021; 29(21): 1215 doi: 10.11569/wcjd.v29.i21.1215
|
| 33 |
Huapeng Lin, Lingfeng Zeng, Jing Yang, Wei Hu, Ying Zhu. A Machine Learning-Based Model to Predict Survival After Transarterial Chemoembolization for BCLC Stage B Hepatocellular Carcinoma. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.608260
|
| 34 |
Jian-Ping Chen, Ri-Hui Yang, Tian-Hui Zhang, Li-An Liao, Yu-Ting Guan, Hai-Yang Dai. Pre-operative enhanced magnetic resonance imaging combined with clinical features predict early recurrence of hepatocellular carcinoma after radical resection. World Journal of Gastrointestinal Oncology 2024; 16(4): 1192-1203 doi: 10.4251/wjgo.v16.i4.1192
|
| 35 |
AM Attallah, MS Albannan, MS El-Deen, K Farid, FM Khedr, KA Attallah, SO Abdallah. Diagnostic role of collagen-III and matrix metalloproteinase-1 for early detection of hepatocellular carcinoma. British Journal of Biomedical Science 2020; 77(2): 58 doi: 10.1080/09674845.2019.1708534
|
| 36 |
Min Shi, Jun-Su Jia, Guo-Sheng Gao, Xin Hua. Advances and challenges of exosome-derived noncoding RNAs for hepatocellular carcinoma diagnosis and treatment. Biochemistry and Biophysics Reports 2024; 38: 101695 doi: 10.1016/j.bbrep.2024.101695
|
| 37 |
Diamantis I. Tsilimigras, Dimitrios Moris, J. Madison Hyer, Fabio Bagante, Francesca Ratti, Hugo P. Marques, Olivier Soubrane, Vincent Lam, George A. Poultsides, Irinel Popescu, Sorin Alexandrescu, Guillaume Martel, Aklile Workneh, Alfredo Guglielmi, Tom Hugh, Luca Aldrighetti, Itaru Endo, Timothy M. Pawlik. Serum α-Fetoprotein Levels at Time of Recurrence Predict Post-Recurrence Outcomes Following Resection of Hepatocellular Carcinoma. Annals of Surgical Oncology 2021; 28(12): 7673 doi: 10.1245/s10434-021-09977-x
|
| 38 |
Shoufei Jiao, Guanqun Li, Dongxin Zhang, Yingchen Xu, Jie Liu, Guangming Li. Anatomic versus non-anatomic resection for hepatocellular carcinoma, do we have an answer? A meta-analysis. International Journal of Surgery 2020; 80: 243 doi: 10.1016/j.ijsu.2020.05.008
|
| 39 |
Qing Wang, Ye Sheng, Zhenxing Jiang, Haifeng Liu, Haitao Lu, Wei Xing. What Imaging Modality Is More Effective in Predicting Early Recurrence of Hepatocellular Carcinoma after Hepatectomy Using Radiomics Analysis: CT or MRI or Both?. Diagnostics 2023; 13(12): 2012 doi: 10.3390/diagnostics13122012
|
| 40 |
Lilia Turcios, Eduardo Chacon, Catherine Garcia, Pedro Eman, Virgilius Cornea, Jieyun Jiang, Brett Spear, Chunming Liu, David S. Watt, Francesc Marti, Roberto Gedaly, Masaru Katoh. Autophagic flux modulation by Wnt/β-catenin pathway inhibition in hepatocellular carcinoma. PLOS ONE 2019; 14(2): e0212538 doi: 10.1371/journal.pone.0212538
|
| 41 |
Zhongwei Xu, Jun Bao, Xiaohan Jin, Heng Li, Kaiyuan Fan, Zhidong Wu, Min Yao, Yan Zhang, Gang Liu, Dan Wang, Xiaoping Yu, Jia Guo, Ruicheng Xu, Qian Gong, Fengmei Wang, Jin Wang. The Effects of Cinobufagin on Hepatocellular Carcinoma Cells Enhanced by MRT68921, an Autophagy Inhibitor. The American Journal of Chinese Medicine 2023; 51(06): 1595 doi: 10.1142/S0192415X23500726
|
| 42 |
Yu Jin Kim, Nayeong Yuk, Hee Jeong Shin, Hye Jin Jung. The Natural Pigment Violacein Potentially Suppresses the Proliferation and Stemness of Hepatocellular Carcinoma Cells In Vitro. International Journal of Molecular Sciences 2021; 22(19): 10731 doi: 10.3390/ijms221910731
|
| 43 |
Satoyoshi Yamashita, Akira Kato, Toshitaka Akatsuka, Takashi Sawada, Tomohide Asai, Noriyuki Koyama, Kiwamu Okita. Clinical relevance of increased serum preneoplastic antigen in hepatitis C-related hepatocellular carcinoma. World Journal of Gastroenterology 2020; 26(13): 1463-1473 doi: 10.3748/wjg.v26.i13.1463
|
| 44 |
Spyridon Davakis, Michail Vailas, Alexandros Kozadinos, Panagiotis Sakarellos, Anastasia Karampa, Dimitrios Korkolis, Georgios Glantzounis, Alexandros Papalampros, Evangelos Felekouras. Hepatocellular Carcinoma - Challenges and Opportunities of a Multidisciplinary Approach. 2022; doi: 10.5772/intechopen.100231
|
| 45 |
Walid M. Ghorab, Samiha.A. El-Sebaey, Mostafa M. Ghorab. Design, synthesis and Molecular modeling study of certain EGFR inhibitors with a quinazolinone scaffold as anti-hepatocellular carcinoma and Radio-sensitizers. Bioorganic Chemistry 2023; 131: 106310 doi: 10.1016/j.bioorg.2022.106310
|
| 46 |
Bin Chen, Xin Xu, Wei Wu, Ke Zheng, Yijun Yu, Dorota L. Stankowska. LINC00659 Inhibits Hepatocellular Carcinoma Malignant Progression by Blocking Aerobic Glycolysis through FUS Recruitment and SLC10A1 Modulation. Analytical Cellular Pathology 2023; 2023: 1 doi: 10.1155/2023/5852963
|
| 47 |
Akram M. Shaaban, Maryam Rezvani, Philip R. Chapman. Imagerie Oncologique. 2022; : 404 doi: 10.1016/B978-2-294-77099-9.00027-2
|
| 48 |
Badriya Baig, Sulafa Abdel Halim, Aaminah Farrukh, Yaser Greish, Amr Amin. Current status of nanomaterial-based treatment for hepatocellular carcinoma. Biomedicine & Pharmacotherapy 2019; 116: 108852 doi: 10.1016/j.biopha.2019.108852
|
| 49 |
Long-Shan Yang, Lun-Jie Yan, Guang-Xiao Meng, Zi-Niu Ding, Sheng-Yu Yao, Hai-Chao Li, Zhao-Ru Dong, Zhi-Qiang Chen, Jian-Guo Hong, Tao Li. The Association of Glycemic Index, Glycemic Load, and Daily Carbohydrates Intake with the Risk of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis. Nutrition and Cancer 2023; 75(2): 461 doi: 10.1080/01635581.2022.2149822
|
| 50 |
Badrinathan Sridharan, Naveen Devarajan, Rupal Jobanputra, Genekehal Siddaramana Gowd, Ida Mulayirikkal Anna, Anusha Ashokan, Shantikumar Nair, Manzoor Koyakutty. nCP:Fe Nanocontrast Agent for Magnetic Resonance Imaging-Based Early Detection of Liver Cirrhosis and Hepatocellular Carcinoma. ACS Applied Bio Materials 2021; 4(4): 3398 doi: 10.1021/acsabm.1c00001
|
| 51 |
Santino Caserta, Sebastiano Gangemi, Giuseppe Murdaca, Alessandro Allegra. Gender Differences and miRNAs Expression in Cancer: Implications on Prognosis and Susceptibility. International Journal of Molecular Sciences 2023; 24(14): 11544 doi: 10.3390/ijms241411544
|
| 52 |
Asmaa Elkhamesy, Manar Refaat, Mona S. O. Gouida, Salma S. Alrdahe, Magdy M. Youssef.
Diminished CCl
4
‐induced hepatocellular carcinoma, oxidative stress, and apoptosis by co‐administration of curcumin or selenium in mice
. Journal of Food Biochemistry 2022; 46(4) doi: 10.1111/jfbc.13845
|
| 53 |
Yiran Yuan, Xiaomin Zhang, Xiaoxiao Wang, Lei Zhang, Jiefeng He. The emerging roles of circHECTD1 in human diseases and the specific underlying regulatory mechanisms. PeerJ 2024; 12: e17612 doi: 10.7717/peerj.17612
|
| 54 |
Yuan Li, Zhong Li, Yunhao Jia, Bo Ding, Jinsong Yu. In Vitro Anti-hepatoma Activities of Notoginsenoside R1 Through Downregulation of Tumor Promoter miR-21. Digestive Diseases and Sciences 2020; 65(5): 1364 doi: 10.1007/s10620-019-05856-4
|
| 55 |
Huijie Gao, Weibo Niu, Zhaobin He, Chao Gao, Cheng Peng, Jun Niu. SEC61G plays an oncogenic role in hepatocellular carcinoma cells. Cell Cycle 2020; 19(23): 3348 doi: 10.1080/15384101.2020.1843816
|
| 56 |
Jianguo Li, Jin Zhou, Shuangshuang Kai, Can Wang, Daijun Wang, Jiying Jiang, Tao Huang. Network-Based Coexpression Analysis Identifies Functional and Prognostic Long Noncoding RNAs in Hepatocellular Carcinoma. BioMed Research International 2020; 2020: 1 doi: 10.1155/2020/1371632
|
| 57 |
Luzie A. Doemel, Jessica G. Santana, Lynn J. Savic, Fabian M. Laage Gaupp, Tabea Borde, Alexandra Petukhova-Greenstein, Ahmet S. Kucukkaya, Isabel T. Schobert, Charlie A. Hamm, Bernhard Gebauer, John J. Walsh, Irvin Rexha, Fahmeed Hyder, MingDe Lin, David C. Madoff, Todd Schlachter, Julius Chapiro, Daniel Coman. Comparison of metabolic and immunologic responses to transarterial chemoembolization with different chemoembolic regimens in a rabbit VX2 liver tumor model. European Radiology 2022; 32(4): 2437 doi: 10.1007/s00330-021-08337-3
|
| 58 |
Jing Yang, Xiujuan Zhang, Leilei Liu, Xin Yang, Qingfu Qian, Bin Du. c-Src promotes the growth and tumorigenesis of hepatocellular carcinoma via the Hippo signaling pathway. Life Sciences 2021; 264: 118711 doi: 10.1016/j.lfs.2020.118711
|
| 59 |
Ki-Hyun Kim, Hyung-Hoon Oh, Dong-Jun Son, Ji-Yoon Hong, Young-Hoon Jeong, Jin-Seong Jung, Hyeong-Min Yu, Dae-Seong Myung, Sung-Bum Cho, Wan-Sik Lee, Jin-Woong Kim, Young-Eun Joo. Scapular metastasis of hepatocellular carcinoma presenting as acute bleeding and hematoma. Medicine 2017; 96(46): e8736 doi: 10.1097/MD.0000000000008736
|
| 60 |
Jie Liu, Yue Wei, Tao Wang, Zhexiao Zhang, Hairong Huang, Chenfei Wang, Huawen Li, Qing Jia, Hongfu Wu, Tangbin Zou. The prognostic significance of long non-coding RNAs in hepatocellular carcinoma: An updated meta-analysis. The International Journal of Biological Markers 2020; 35(4): 3 doi: 10.1177/1724600820965579
|
| 61 |
Linhe Wang, Xiangchao Ling, Caihui Zhu, Zhiheng Zhang, Ziming Wang, Shanzhou Huang, Yunhua Tang, Shujiao He, Zhiyong Guo, Xiaoshun He. Upregulated Seizure-Related 6 Homolog-Like 2 Is a Prognostic Predictor of Hepatocellular Carcinoma. Disease Markers 2020; 2020: 1 doi: 10.1155/2020/7318703
|
| 62 |
Rusdina Bte Ladju, Zulvikar Syambani Ulhaq, Gita Vita Soraya. Nanotheranostics: A powerful next-generation solution to tackle hepatocellular carcinoma. World Journal of Gastroenterology 2022; 28(2): 176-187 doi: 10.3748/wjg.v28.i2.176
|
| 63 |
Akira Hokama, Shingo Arakaki, Shinichiro Ishino, Yutaka Nakagawa, Souhei Tabata, Daiki Agarie, Satoshi Kuwae, Ryuta Zukeyama, Tatsuji Maeshiro, Yuma Tsuruta, Akiko Matsuzaki, Naoki Wada, Mitsuhisa Takatsuki, Jiro Fujita. Hepatocellular Carcinoma in a Patient With Crohn’s Disease. Cureus 2021; doi: 10.7759/cureus.16570
|
| 64 |
Mohamed Fawzi Kabil, Sara A. Abdel Gaber, Mohamed A. Hamzawy, Ibrahim M. El-Sherbiny, Maha Nasr. Folic/lactobionic acid dual-targeted polymeric nanocapsules for potential treatment of hepatocellular carcinoma. Drug Delivery and Translational Research 2024; 14(5): 1338 doi: 10.1007/s13346-023-01467-9
|
| 65 |
Defa Huang, Dingyu Rao, Qing Jin, Mi Lai, Jiali Zhang, Zhonghong Lai, Haibin Shen, Tianyu Zhong. Role of CD147 in the development and diagnosis of hepatocellular carcinoma. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1149931
|
| 66 |
Zheng Yu, Rongchang Wang, Fan Chen, Jianru Wang, Xiaohui Huang. Five Novel Oncogenic Signatures Could Be Utilized as AFP-Related Diagnostic Biomarkers for Hepatocellular Carcinoma Based on Next-Generation Sequencing. Digestive Diseases and Sciences 2018; 63(4): 945 doi: 10.1007/s10620-018-4961-3
|
| 67 |
Wei Zhang, Zhong Chen, Chengjun Xue, Yao Zhang, Lipei Wu, Jichao Zhu, Shihai Xuan, Jiale Tian, Zhi Pang. The Applicability of ADA, AFU, and LAC in the Early Diagnosis and Disease Risk Assessment of Hepatitis B-Associated Liver Cirrhosis and Hepatocellular Carcinoma. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.740029
|
| 68 |
Taibai Jiang, Guangtong Xie, Zhirui Zeng, Junjie Lan, Hanfei Liu, Jinyu Li, Hai Ren, Tengxiang Chen, Weidong Pan. A novel class of C14-sulfonate-tetrandrine derivatives as potential chemotherapeutic agents for hepatocellular carcinoma. Frontiers in Chemistry 2023; 10 doi: 10.3389/fchem.2022.1107824
|
| 69 |
Fanbo Qin, Junyong Zhang, Jianping Gong, Wenfeng Zhang, Shibiao Wan. Identification and Validation of a Prognostic Model Based on Three Autophagy-Related Genes in Hepatocellular Carcinoma. BioMed Research International 2021; 2021: 1 doi: 10.1155/2021/5564040
|
| 70 |
Wenyue Zhang, Juan Huang, Yao Tang, Yixuan Yang, Huaidong Hu. Inhibition of fatty acid synthase (FASN) affects the proliferation and apoptosis of HepG2 hepatoma carcinoma cells via the β-catenin/C-myc signaling pathway. Annals of Hepatology 2020; 19(4): 411 doi: 10.1016/j.aohep.2020.03.005
|
| 71 |
Nikolaos Garmpis, Christos Damaskos, Anna Garmpi, Vasiliki E. Georgakopoulou, Panagiotis Sarantis, Efstathios A. Antoniou, Michalis V. Karamouzis, Afroditi Nonni, Dimitrios Schizas, Evangelos Diamantis, Evangelos Koustas, Paraskevi Farmaki, Athanasios Syllaios, Alexandros Patsouras, Konstantinos Kontzoglou, Nikolaos Trakas, Dimitrios Dimitroulis. Histone Deacetylase Inhibitors in the Treatment of Hepatocellular Carcinoma: Current Evidence and Future Opportunities. Journal of Personalized Medicine 2021; 11(3): 223 doi: 10.3390/jpm11030223
|
| 72 |
Dimitrios Dimitroulis, Christos Damaskos, Nikolaos Garmpis, Anna Garmpi. Liver Cancer - Multidisciplinary Approach. 2024; doi: 10.5772/intechopen.1004995
|
| 73 |
Jeffrey Olpin, Dominik Geisel. Diagnostic Imaging: Onkologie. 2022; : 415 doi: 10.1016/B978-3-437-24031-7.00027-6
|
| 74 |
Teresa Marzia Rogger, Andrea Michielan, Sandro Sferrazza, Cecilia Pravadelli, Luisa Moser, Flora Agugiaro, Giovanni Vettori, Sonia Seligmann, Elettra Merola, Marcello Maida, Francesco Antonio Ciarleglio, Alberto Brolese, Giovanni de Pretis. Gastrointestinal tract injuries after thermal ablative therapies for hepatocellular carcinoma: A case report and review of the literature. World Journal of Gastroenterology 2020; 26(35): 5375-5386 doi: 10.3748/wjg.v26.i35.5375
|
| 75 |
María V Espelt, María L Bacigalupo, Pablo Carabias, María F Troncoso. MicroRNAs contribute to ATP-binding cassette transporter- and autophagy-mediated chemoresistance in hepatocellular carcinoma. World Journal of Hepatology 2019; 11(4): 344-358 doi: 10.4254/wjh.v11.i4.344
|
| 76 |
Danni Li, Shaogang Liu, Jiahao Zhu, Liqun Shen, Qi ying Zhang, Hua Zhu. Folic acid modified TPGS as a novel nano-micelle for delivery of nitidine chloride to improve apoptosis induction in Huh7 human hepatocellular carcinoma. BMC Pharmacology and Toxicology 2021; 22(1) doi: 10.1186/s40360-020-00461-y
|
| 77 |
Dashuai Yang, Fangrui Zhao, Yang Su, Yu Zhou, Jie Shen, Bin Yu, Kailiang Zhao, Youming Ding. Integrated analysis of single-cell and bulk RNA-sequencing identifies a signature based on NK cell marker genes to predict prognosis and immunotherapy response in hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology 2023; 149(12): 10609 doi: 10.1007/s00432-023-04965-y
|
| 78 |
Xiao Fu, Wenyue Zhang, Shiying Li, Ning Ling, Yixuan Yang, Zhang Dazhi. Identification of alanine aminotransferase 1 interaction network via iTRAQ-based proteomics in alternating migration, invasion, proliferation and apoptosis of HepG2 cells. Aging 2022; 14(17): 7137 doi: 10.18632/aging.204286
|
| 79 |
Hua-Ming Cheng, Toshihiro Tanaka, Hideyuki Nishiofuku, Yuto Chanoki, Katsutoshi Horiuchi, Tetsuya Masada, Shota Tatsumoto, Takeshi Matsumoto, Nagaaki Marugami, Kimihiko Kichikawa. Safety and Prognosis of Transarterial Chemoembolization for Octogenarians with Hepatocellular Carcinoma. CardioVascular and Interventional Radiology 2019; 42(10): 1413 doi: 10.1007/s00270-019-02290-x
|
| 80 |
Abhiram Natu, Anjali Singh, Sanjay Gupta. Hepatocellular carcinoma: Understanding molecular mechanisms for defining potential clinical modalities. World Journal of Hepatology 2021; 13(11): 1568-1583 doi: 10.4254/wjh.v13.i11.1568
|
| 81 |
Nikita Thapa, Yong Chwae, Kwang Yoo, Tae-Bin Won, Daewook Kang, Daae Choi, Jaeyoung Kim. Exosomal delivery of TRAIL and miR‑335 for the treatment of hepatocellular carcinoma (Review). International Journal of Molecular Medicine 2022; 51(1) doi: 10.3892/ijmm.2022.5206
|
| 82 |
Yong-Guang Wei, Cheng-Kun Yang, Zhong-Liu Wei, Xi-Wen Liao, Yong-Fei He, Xin Zhou, Hua-Sheng Huang, Chen-Lu Lan, Chuang-Ye Han, Tao Peng. High-Mobility Group AT-Hook 1 Served as a Prognosis Biomarker and Associated with Immune Infiltrate in Hepatocellular Carcinoma. International Journal of General Medicine 2022; : 609 doi: 10.2147/IJGM.S344858
|
| 83 |
Divya Niveditha, Sudeshna Mukherjee, Syamantak Majumder, Rajdeep Chowdhury, Shibasish Chowdhury, Inanc Birol. A global transcriptomic pipeline decoding core network of genes involved in stages leading to acquisition of drug-resistance to cisplatin in osteosarcoma cells. Bioinformatics 2019; 35(10): 1701 doi: 10.1093/bioinformatics/bty868
|
| 84 |
Gangfeng Hu, Xia Huang, Bo Zhang, Pingfa Gao, Wei Wu, Jun Wang. Identify an innovative ferroptosis‐related gene in hepatocellular carcinoma. Journal of Clinical Laboratory Analysis 2022; 36(9) doi: 10.1002/jcla.24632
|
| 85 |
Iason Psilopatis, Christos Damaskos, Anna Garmpi, Panagiotis Sarantis, Evangelos Koustas, Efstathios A. Antoniou, Dimitrios Dimitroulis, Gregory Kouraklis, Michail V. Karamouzis, Kleio Vrettou, Georgios Marinos, Konstantinos Kontzoglou, Nikolaos Garmpis. FDA-Approved Monoclonal Antibodies for Unresectable Hepatocellular Carcinoma: What Do We Know So Far?. International Journal of Molecular Sciences 2023; 24(3): 2685 doi: 10.3390/ijms24032685
|
| 86 |
Han-Yu Jiang, Jie Chen, Chun-Chao Xia, Li-Kun Cao, Ting Duan, Bin Song. Noninvasive imaging of hepatocellular carcinoma: From diagnosis to prognosis. World Journal of Gastroenterology 2018; 24(22): 2348-2362 doi: 10.3748/wjg.v24.i22.2348
|
| 87 |
Lan Zhang, Yuling Zou, Yingying Lu, Zhijia Li, Feng Gao. Unraveling the therapeutic potential of carbamoyl phosphate synthetase 1 (CPS1) in human diseases. Bioorganic Chemistry 2023; 130: 106253 doi: 10.1016/j.bioorg.2022.106253
|
| 88 |
Wenbiao Chen, Donge Tang, Minglin Ou, Yong Dai. Mining Prognostic Biomarkers of Hepatocellular Carcinoma Based on Immune-Associated Genes. DNA and Cell Biology 2020; 39(4): 499 doi: 10.1089/dna.2019.5099
|
| 89 |
Ronik S. Bhangoo, Trey C. Mullikin, Jonathan B. Ashman, Tiffany W. Cheng, Michael A. Golafshar, Todd A. DeWees, Jedediah E. Johnson, Satomi Shiraishi, Wei Liu, Yanle Hu, Kenneth W. Merrell, Michael G. Haddock, Sunil Krishnan, William G. Rule, Terence T. Sio, Christopher L. Hallemeier. Intensity Modulated Proton Therapy for Hepatocellular Carcinoma: Initial Clinical Experience. Advances in Radiation Oncology 2021; 6(4): 100675 doi: 10.1016/j.adro.2021.100675
|
| 90 |
Olga Y. Burenina, Natalia L. Lazarevich, Inna F. Kustova, Daria A. Shavochkina, Ekaterina A. Moroz, Nikolay E. Kudashkin, Yuriy I. Patyutko, Alexey V. Metelin, Eduard F. Kim, Dmitry A. Skvortsov, Timofei S. Zatsepin, Maria P. Rubtsova, Olga A. Dontsova. Panel of potential lncRNA biomarkers can distinguish various types of liver malignant and benign tumors. Journal of Cancer Research and Clinical Oncology 2021; 147(1): 49 doi: 10.1007/s00432-020-03378-5
|
| 91 |
Tian Zuo, Zuo Zhang, Peng Jiang, Rui Zhang, Danni Ni, Yuan Yuan, Shaopeng Zhang. Characterization of chikusetsusaponin IV and V induced apoptosis in HepG2 cancer cells. Molecular Biology Reports 2022; 49(6): 4247 doi: 10.1007/s11033-022-07259-7
|
| 92 |
Alicia Furumaya, Otto M. van Delden, Roeland F. de Wilde, Judith de Vos-Geelen, Lydia G. van der Geest. Impact of COVID-19 on Incidence, Treatment, and Survival of Patients with Hepatocellular Carcinoma in the Netherlands. Disaster Medicine and Public Health Preparedness 2024; 18 doi: 10.1017/dmp.2024.176
|
| 93 |
Chao An, Hongcai Yang, Xiaoling Yu, Zhi-Yu Han, Zhigang Cheng, Fangyi Liu, Jianping Dou, Bing Li, Yansheng Li, Yichao Li, Jie Yu, Ping Liang. A Machine Learning Model Based on Health Records for Predicting Recurrence After Microwave Ablation of Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 2022; : 671 doi: 10.2147/JHC.S358197
|
| 94 |
L.S.S. Srivani Nagam, Ramakrishna Vadde, Rajeswari Jinka. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma. 2022; : 125 doi: 10.1016/B978-0-323-98806-3.00013-1
|
| 95 |
Hamzah Adwan, Thomas J. Vogl, Ümniye Balaban, Nour-Eldin Abdelrehim Nour-Eldin. Percutaneous Thermal Ablation Therapy of Hepatocellular Carcinoma (HCC): Microwave Ablation (MWA) versus Laser-Induced Thermotherapy (LITT). Diagnostics 2022; 12(3): 564 doi: 10.3390/diagnostics12030564
|
| 96 |
Ravikiran Tekupalli, Santosh Anand, Sowbhagya Ramachandregowda, Anupama Sindhghatta Kariyappa. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 2. 2022; : 195 doi: 10.1016/B978-0-323-98807-0.00019-3
|
| 97 |
Dimitrios Moris, Diamantis I. Tsilimigras, Ioannis D. Kostakis, Ioannis Ntanasis-Stathopoulos, Kevin N. Shah, Evangelos Felekouras, Timothy M. Pawlik. Anatomic versus non-anatomic resection for hepatocellular carcinoma: A systematic review and meta-analysis. European Journal of Surgical Oncology 2018; 44(7): 927 doi: 10.1016/j.ejso.2018.04.018
|
| 98 |
Omaima Mohamed Ali, Hussein Ahmed El Amin, Yousry Lotfy Sharkawy, Adnan Ahmed Mohamed Ali, Emad Farah Mohammed Kholef, Wael Abd Elgwad Elsewify. <p>Golgi Protein 73 versus Alpha-Fetoprotein as a New Biomarker in Early Diagnosis of Hepatocellular Carcinoma</p>. International Journal of General Medicine 2020; : 193 doi: 10.2147/IJGM.S253622
|
| 99 |
Divya R, Radha P. An Optimized HCC Recurrence Prediction Using APO Algorithm Multiple Time Series Clinical Liver Cancer Dataset. Journal of Medical Systems 2019; 43(7) doi: 10.1007/s10916-019-1265-x
|
| 100 |
Roseane Guimarães Ferreira, Magda Vieira Cardoso, Karine Maria de Souza Furtado, Kaio Murilo Monteiro Espíndola, Ruanderson Pereira Amorim, Marta Chagas Monteiro. Epigenetic alterations caused by aflatoxin b1: a public health risk in the induction of hepatocellular carcinoma. Translational Research 2019; 204: 51 doi: 10.1016/j.trsl.2018.09.001
|
| 101 |
Saixin Li, Zeyu Zhang, Zheng Wang, Kenan Wang, Minghao Sui, Dongbin Liu, Kuo Liang. Lenvatinib‑based treatment regimens in conversion therapy of unresectable hepatocellular carcinoma: A systematic review and meta‑analysis. Oncology Letters 2024; 27(6) doi: 10.3892/ol.2024.14398
|
| 102 |
Jacek Hawiger, Jozef Zienkiewicz. Decoding inflammation, its causes, genomic responses, and emerging countermeasures. Scandinavian Journal of Immunology 2019; 90(6) doi: 10.1111/sji.12812
|
| 103 |
Weibo Du, Wenbiao Chen, Zheyue Shu, Dairong Xiang, Kefan Bi, Yingfeng Lu, Xujun Zhang, Lanjuan Li, Hongyan Diao. Identification of Prognostic Biomarkers of Hepatocellular Carcinoma Via Long Noncoding RNA Expression and Copy Number Alterations. Epigenomics 2020; 12(15): 1303 doi: 10.2217/epi-2019-0385
|
| 104 |
Lianxiang Luo, Xinyue Yao, Jing Xiang, Fangfang Huang, Hui Luo. Identification of ferroptosis-related genes for overall survival prediction in hepatocellular carcinoma. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-14554-7
|
| 105 |
Georgia Sofia Karachaliou, Nikolaos Dimitrokallis, Dimitrios P Moris. Downstaging strategies for unresectable hepatocellular carcinoma. World Journal of Gastroenterology 2024; 30(20): 2731-2733 doi: 10.3748/wjg.v30.i20.2731
|
| 106 |
Xiancheng Ou, Bikash Karmakar, Nasser S. Awwad, Hala A. Ibrahium, Hosam-Eldin Hussein Osman, Attalla F. El-kott, Mohamed M. Abdel-Daim. Au nanoparticles adorned chitosan-modified magnetic nanocomposite: An investigation towards its antioxidant and anti-hepatocarcinoma activity in vitro. Inorganic Chemistry Communications 2022; 137: 109221 doi: 10.1016/j.inoche.2022.109221
|
| 107 |
Jianwei Wang, Xiaowen Guan, Ning Shang, Di Wu, Zihan Liu, Zhenzhen Guan, Zhizi Zhang, Zhongzhen Jin, Xiaoyi Wei, Xiaoran Liu, Mingzhu Song, Weijun Zhu, Guifu Dai. Dysfunction of CCT3-associated network signals for the critical state during progression of hepatocellular carcinoma. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2024; 1870(4): 167054 doi: 10.1016/j.bbadis.2024.167054
|
| 108 |
Minoru Yamakado, Takayuki Tanaka, Kenji Nagao, Akira Imaizumi, Michiharu Komatsu, Takashi Daimon, Hiroshi Miyano, Mizuki Tani, Akiko Toda, Hiroshi Yamamoto, Katsuhisa Horimoto, Yuko Ishizaka. Plasma amino acid profile associated with fatty liver disease and co-occurrence of metabolic risk factors. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-14974-w
|
| 109 |
Yuming Jia, Shengchao Li, Meng Zhang, Zhilei Zhang, Chao Wang, Chong Zhang, Wuhan Yang, Li Peng, Zhuo Xu. Circ_LDLR Knockdown Suppresses Progression of Hepatocellular Carcinoma via Modulating miR-7/RNF38 Axis. Cancer Management and Research 2021; : 337 doi: 10.2147/CMAR.S275003
|
| 110 |
Soo-Hyeon Kim, Byung-Joon Seung, Seung-Hee Cho, Ha-Young Lim, Min-Kyung Bae, Jung-Hyang Sur. Arginase-1 and P-glycoprotein are downregulated in canine hepatocellular carcinoma. Journal of Veterinary Science 2021; 22(5) doi: 10.4142/jvs.2021.22.e61
|
| 111 |
Shuangmei Zhao, Yongqi Zhen, Leilei Fu, Feng Gao, Xianli Zhou, Shuai Huang, Lan Zhang. Design, synthesis and biological evaluation of benzamide derivatives as novel NTCP inhibitors that induce apoptosis in HepG2 cells. Bioorganic & Medicinal Chemistry Letters 2019; 29(19): 126623 doi: 10.1016/j.bmcl.2019.126623
|
| 112 |
Maria Corina Plaz Torres, Quirino Lai, Fabio Piscaglia, Eugenio Caturelli, Giuseppe Cabibbo, Elisabetta Biasini, Filippo Pelizzaro, Fabio Marra, Franco Trevisani, Edoardo G. Giannini. Treatment of Hepatocellular Carcinoma with Immune Checkpoint Inhibitors and Applicability of First-Line Atezolizumab/Bevacizumab in a Real-Life Setting. Journal of Clinical Medicine 2021; 10(15): 3201 doi: 10.3390/jcm10153201
|
| 113 |
Christos Damaskos, Nikolaos Garmpis, Dimitrios Dimitroulis, Anna Garmpi, Iason Psilopatis, Panagiotis Sarantis, Evangelos Koustas, Prodromos Kanavidis, Dionysios Prevezanos, Gregory Kouraklis, Michail V. Karamouzis, Georgios Marinos, Konstantinos Kontzoglou, Efstathios A. Antoniou. Targeted Therapies for Hepatocellular Carcinoma Treatment: A New Era Ahead—A Systematic Review. International Journal of Molecular Sciences 2022; 23(22): 14117 doi: 10.3390/ijms232214117
|
| 114 |
Arno Kornberg, Helmut Friess. 18F-fludeoxyglucose positron emission tomography for diagnosis of HCC: implications for therapeutic strategy in curative and non-curative approaches. Therapeutic Advances in Gastroenterology 2019; 12 doi: 10.1177/1756284819836205
|
| 115 |
Mengxue He, Ling Yu, Yuanyuan Yang, Binhua Zou, Wen Ma, Meng Yu, Jiandong Lu, Guoliang Xiong, Zhiqiang Yu, Aimin Li. Delivery of triptolide with reduction-sensitive polymer nanoparticles for liver cancer therapy on patient-derived xenografts models. Chinese Chemical Letters 2020; 31(12): 3178 doi: 10.1016/j.cclet.2020.05.034
|
| 116 |
Georgios K. Glantzounis, Dimitrios Korkolis, Georgios C. Sotiropoulos, Georgios Tzimas, Anastasia Karampa, Athanasios Paliouras, Alexandros-Georgios Asimakopoulos, Spyridon Davakis, Alexandros Papalampros, Dimitrios Moris, Evangelos Felekouras. Individualized Approach in the Surgical Management of Hepatocellular Carcinoma: Results from a Greek Multicentre Study. Cancers 2022; 14(18): 4387 doi: 10.3390/cancers14184387
|
| 117 |
Jesús Rafael Rodríguez-Aguilera, Rebeca Pérez-Cabeza de Vaca, Nuria Guerrero-Celis, Gabriela Velasco-Loyden, Mariana Domínguez-López, Félix Recillas-Targa, Victoria Chagoya de Sánchez. Liver Cirrhosis - Debates and Current Challenges. 2019; doi: 10.5772/intechopen.83481
|
| 118 |
Hamzah Adwan, Lars Hammann, Thomas J. Vogl. Microwave Ablation of Recurrent Hepatocellular Carcinoma after Curative Surgical Resection. Journal of Clinical Medicine 2023; 12(7): 2560 doi: 10.3390/jcm12072560
|
| 119 |
Yang Li, An Jiang. ST8SIA6-AS1 promotes hepatocellular carcinoma by absorbing miR-5195-3p to regulate HOXB6. Cancer Biology & Therapy 2020; 21(7): 647 doi: 10.1080/15384047.2020.1743150
|
| 120 |
Peng-Sheng Yi, Chen-Jun Hu, Chen-Hui Li, Fei Yu. Clinical value of artificial intelligence in hepatocellular carcinoma: Current status and prospect. Artificial Intelligence in Gastroenterology 2021; 2(2): 42-55 doi: 10.35712/aig.v2.i2.42
|
| 121 |
Mohib Ullah Kakar, Muhammad Zubair Mehboob, Muhammad Akram, Muddaser Shah, Yasmeen Shakir, Hafza Wajeeha Ijaz, Ubair Aziz, Zahid Ullah, Sajjad Ahmad, Sikandar Ali, Yongxiang Yin, Kun Li. Identification of Differentially Expressed Genes Associated with the Prognosis and Diagnosis of Hepatocellular Carcinoma by Integrated Bioinformatics Analysis. BioMed Research International 2022; 2022: 1 doi: 10.1155/2022/4237633
|
| 122 |
EmadA Awad, TarekM Youssef, MohamedO Aly, AzzaA R. Saab. Clinical utility of serum chromogranin A as a marker of hepatocellular carcinoma in chronic hepatitis patients. The Egyptian Journal of Laboratory Medicine 2020; 32(3): 76 doi: 10.4103/ejolm.ejolm_10_21
|
| 123 |
Yunxi Liu, Yue Chen, Weidong Fei, Caihong Zheng, Yongquan Zheng, Miao Tang, Ying Qian, Xiao Zhang, Mengdan Zhao, Meng Zhang, Fengmei Wang. Silica-Based Nanoframeworks Involved Hepatocellular Carcinoma Theranostic. Frontiers in Bioengineering and Biotechnology 2021; 9 doi: 10.3389/fbioe.2021.733792
|
| 124 |
Bart Vanderborght, Kevin De Muynck, Sander Lefere, Anja Geerts, Helena Degroote, Xavier Verhelst, Hans Van Vlierberghe, Lindsey Devisscher. Effect of isoform-specific HIF-1α and HIF-2α antisense oligonucleotides on tumorigenesis, inflammation and fibrosis in a hepatocellular carcinoma mouse model. Oncotarget 2020; 11(48): 4504 doi: 10.18632/oncotarget.27830
|
| 125 |
Mohamed Fawzi Kabil, Maha Nasr, Ibrahim M. El-Sherbiny. Conventional and hybrid nanoparticulate systems for the treatment of hepatocellular carcinoma: An updated review. European Journal of Pharmaceutics and Biopharmaceutics 2021; 167: 9 doi: 10.1016/j.ejpb.2021.07.003
|
| 126 |
D. V. Sidorov, M. V. Lozhkin, L. O. Petrov, A. G. Isaeva, M. S. Gusakova. Combined extensive liver resections in patients with locally advanced hepatocellular cancer – clinical cases. Research and Practical Medicine Journal 2020; 7(2): 154 doi: 10.17709/2409-2231-2020-7-2-14
|
| 127 |
Krishna Chaitanya Amajala, Indu Priya Gudivada, Rama Rao Malla.
Gamma Delta T Cells: Role in Immunotherapy of Hepatocellular Carcinoma
. Critical Reviews™ in Oncogenesis 2023; 28(4): 41 doi: 10.1615/CritRevOncog.2023049893
|
| 128 |
Indranil Banerjee, Paul B. Fisher, Devanand Sarkar. . Advances in Cancer Research 2021; 152: 329 doi: 10.1016/bs.acr.2021.05.003
|
| 129 |
Yangjin Huang, Jun Xu, Chunming Xie, Yuejuan Liao, Rong Lin, Yuan Zeng, Fujun Yu. A Novel Gene Pair CSTF2/DPE2A Impacts Prognosis and Cell Cycle of Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 2023; : 1639 doi: 10.2147/JHC.S413935
|
| 130 |
JieYu Li, WanSong Lin, TianYing Huang, MingShui Chen, QiaoYan Lin. IL-12 improves the anti-HCC efficacy of dendritic cells loaded with exosomes from overexpressing Rab27a tumor cells. Experimental Cell Research 2024; 439(1): 114073 doi: 10.1016/j.yexcr.2024.114073
|
| 131 |
Feiyu Qi, Guiming Zha, Yanfang Zhang, Sihua Liu, Yuhang Yang, Wanliang Sun, Dongdong Wang, Zhong Liu, Zheng Lu, Dengyong Zhang. Integrative analysis of bulk and single-cell transcriptomic data reveals novel insights into lipid metabolism and prognostic factors in hepatocellular carcinoma. Discover Oncology 2024; 15(1) doi: 10.1007/s12672-024-01487-y
|
| 132 |
Rui Kong, Nan Wang, Chun li Zhou, Jie Lu. Prognostic Value of an Immune Long Non-Coding RNA Signature in Liver Hepatocellular Carcinoma. Journal of Microbiology and Biotechnology 2024; 34(4): 958 doi: 10.4014/jmb.2308.08022
|
| 133 |
Zigeng Zhang. MRI monitoring of combined therapy with transcatheter arterial delivery of NK cells and systemic administration of sorafenib for the treatment of HCC. American Journal of Cancer Research 2024; 14(5): 2216 doi: 10.62347/IARO1564
|
| 134 |
AKANKSHA DWIVEDI, RAKHI KHABIYA, ALANKAR SHRIVASTAVA, SIDDHARTH TYAGI, KANDASAMY NAGARAJAN, G. N. DARWHEKAR. MECHANISM OF ACTION, SYNTHESIS, PROPERTIES AND ANALYTICAL METHODS OF CABOZANTINIB. International Journal of Applied Pharmaceutics 2023; : 57 doi: 10.22159/ijap.2023v15i1.46409
|
| 135 |
Derya Mete, Egehan Yemeztaşlıca, Gülşah Şanlı-Mohamed. Sorafenib loaded ZIF-8 metal-organic frameworks as a multifunctional nano-carrier offers effective hepatocellular carcinoma therapy. Journal of Drug Delivery Science and Technology 2023; 82: 104362 doi: 10.1016/j.jddst.2023.104362
|
| 136 |
Umakant Prasad, Deepak Kumar, Rashmi Rani Bharti, Sanjay Kumar Suman, Aishwerya Singh, Ravikant Kumar. Typical and Atypical Imaging Findings of Hepatocellular Carcinoma on Multiphasic MDCT Scan in Histologically Proved Cases. Journal of Gastrointestinal and Abdominal Radiology 2022; 5(03): 135 doi: 10.1055/s-0042-1742771
|
| 137 |
Abdul Mateen, Abad Khan, Ismail Khan, Lateef Ahmad, Amjad Khan, Abdul Salam. Formulation development, characterization, and evaluation of sorafenib-loaded PLGA–chitosan nanoparticles. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1465363
|
| 138 |
Jiejun Hu, Dong Cai, Zhibo Zhao, Guo-Chao Zhong, Jianping Gong. Suppression of Heterogeneous Nuclear Ribonucleoprotein C Inhibit Hepatocellular Carcinoma Proliferation, Migration, and Invasion via Ras/MAPK Signaling Pathway. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.659676
|
| 139 |
Manali Dimri, Ande Satyanarayana. Molecular Signaling Pathways and Therapeutic Targets in Hepatocellular Carcinoma. Cancers 2020; 12(2): 491 doi: 10.3390/cancers12020491
|
| 140 |
Christos Damaskos, Nikolaos Garmpis, Dimitrios Dimitroulis, Anna Garmpi, Evangelos Diamantis, Panagiotis Sarantis, Vasiliki E. Georgakopoulou, Alexandros Patsouras, Markos Despotidis, Dionysios Prevezanos, Athanasios Syllaios, Georgios Marinos, Evangelos Koustas, Christos Vallilas, Efstathios A. Antoniou, Konstantinos Kontzoglou, Spyridon Savvanis, Gregory Kouraklis. The Role of SNHG15 in the Pathogenesis of Hepatocellular Carcinoma. Journal of Personalized Medicine 2022; 12(5): 753 doi: 10.3390/jpm12050753
|
| 141 |
Shahnaz Azzahra, Ulfa Kholili, Rosy Setiawati, Ummi Maimunah. Profile of Patients of Hepatocellular Carcinoma in The Internal Medicine Inpatient Room at Dr. Soetomo General Academic Hospital . Current Internal Medicine Research and Practice Surabaya Journal 2023; 4(1): 1 doi: 10.20473/cimrj.v4i1.42287
|
| 142 |
Yan-Qiong Zhang, Yan Shen, Ming-Mei Liao, Xia Mao, Gu-Jie Mi, Chen You, Qiu-Yan Guo, Wei-Jie Li, Xiao-Yue Wang, Na Lin, Thomas J. Webster. Galactosylated chitosan triptolide nanoparticles for overcoming hepatocellular carcinoma: Enhanced therapeutic efficacy, low toxicity, and validated network regulatory mechanisms. Nanomedicine: Nanotechnology, Biology and Medicine 2019; 15(1): 86 doi: 10.1016/j.nano.2018.09.002
|
| 143 |
Suchandrima Ghosh, Sayantani Bhowmik, Swagata Majumdar, Avijit Goswami, Joyeeta Chakraborty, Subash Gupta, Shaleen Aggarwal, Sukanta Ray, Raghunath Chatterjee, Suvendranath Bhattacharyya, Moumita Dutta, Simanti Datta, Abhijit Chowdhury, Gopal Krishna Dhali, Soma Banerjee. The exosome encapsulated microRNAs as circulating diagnostic marker for hepatocellular carcinoma with low alpha‐fetoprotein. International Journal of Cancer 2020; 147(10): 2934 doi: 10.1002/ijc.33111
|
| 144 |
Anita Alizadeh, Asiyeh Jebelli, Behzad Baradaran, Mohammad Amini, Fatemeh Oroojalian, Mahmoud Hashemzaei, Ahad Mokhtarzadeh, Michael R Hamblin. Crosstalk between long non-coding RNA DLX6-AS1, microRNAs and signaling pathways: A pivotal molecular mechanism in human cancers. Gene 2021; 769: 145224 doi: 10.1016/j.gene.2020.145224
|
| 145 |
志祥 刘. Research Progress on the Predictive Value of Early Curative Effect after TACE for Hepatocellular Carcinoma. Advances in Clinical Medicine 2022; 12(11): 10342 doi: 10.12677/ACM.2022.12111491
|
| 146 |
Yi-Hsuan Hung, Yu-Chuan Lin, Yu-Ting Lin, Guan-Wen Shih, Jiunn-Wang Liao, Kuan-Sheng Chen, Hong-Ming Liu, Yi-Wei Chen, Yung-Jen Chuang, Chia-Min Yang, Jinn-Jer Peir, Chin-Hua Yang, Fong-In Chou. Suitability of boric acid as a boron drug for boron neutron capture therapy for hepatoma. Applied Radiation and Isotopes 2020; 164: 109254 doi: 10.1016/j.apradiso.2020.109254
|
| 147 |
Chunhou Qi, Hongfei Gao, Qinghua Zhao, Lei Zhang. <p>Computed Tomography-Guided Percutaneous Cryoablation for Subcardiac Hepatocellular Carcinoma: Safety, Efficacy, Therapeutic Results and Risk Factors for Survival Outcomes</p>. Cancer Management and Research 2020; : 3333 doi: 10.2147/CMAR.S250652
|
| 148 |
Josef Madrigal, Joseph Hadaya, Cory Lee, Zachary Tran, Peyman Benharash. Association of Frailty with Perioperative Outcomes Following Hepatic Resection: A National Study. Journal of the American Medical Directors Association 2022; 23(4): 684 doi: 10.1016/j.jamda.2022.02.004
|
| 149 |
Qisthina Syifa Setiawan, Zuherman Rustam, Sri Hartini, Afifah Rofi Laeli, Ilsya Wirasati. Comparison of Naive Bayes and Decision Tree for Classifying Hepatocellular Carcinoma (HCC). 2020 International Conference on Innovation and Intelligence for Informatics, Computing and Technologies (3ICT) 2020; : 1 doi: 10.1109/3ICT51146.2020.9312022
|
| 150 |
Archu Singh, Sadat Shafi, Tanya Upadhyay, Abul Kalam Najmi, Kanchan Kohli, Faheem Hyder Pottoo. Insights into Nanotherapeutic Strategies as an Impending Approach to Liver Cancer Treatment. Current Topics in Medicinal Chemistry 2020; 20(20): 1839 doi: 10.2174/1568026620666200624161801
|
| 151 |
Shichao Ding, Yanfeng Jin, Qingzhi Hao, Yanmeng Kang, Ruiping Ma. LncRNA BCYRN1/miR-490-3p/POU3F2, served as a ceRNA network, is connected with worse survival rate of hepatocellular carcinoma patients and promotes tumor cell growth and metastasis. Cancer Cell International 2020; 20(1) doi: 10.1186/s12935-019-1081-x
|
| 152 |
Ya Li, Qiuju Han, Huajun Zhao, Quanjuan Guo, Jian Zhang. Napabucasin Reduces Cancer Stem Cell Characteristics in Hepatocellular Carcinoma. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.597520
|
| 153 |
Mohammed Mehadi Hassan Chowdhury, Christiancel Joseph J. Salazar, Md Nurunnabi. Recent advances in bionanomaterials for liver cancer diagnosis and treatment. Biomaterials Science 2021; 9(14): 4821 doi: 10.1039/D1BM00167A
|
| 154 |
Kwei-Yan Liu, Li-Ting Wang, Shih-Hsien Hsu. Modification of Epigenetic Histone Acetylation in Hepatocellular Carcinoma. Cancers 2018; 10(1): 8 doi: 10.3390/cancers10010008
|
| 155 |
Ling Yu, Zhenjie Wang, Zhuomao Mo, Binhua Zou, Yuanyuan Yang, Rui Sun, Wen Ma, Meng Yu, Shijun Zhang, Zhiqiang Yu. Synergetic delivery of triptolide and Ce6 with light-activatable liposomes for efficient hepatocellular carcinoma therapy. Acta Pharmaceutica Sinica B 2021; 11(7): 2004 doi: 10.1016/j.apsb.2021.02.001
|
| 156 |
De-Ling Wu, Zhen-Dong Liao, Fang-Fang Chen, Wei Zhang, Ya-Shuo Ren, Can-Can Wang, Xiao-Xiao Chen, Dai-Yin Peng, Ling-Yi Kong. Benzophenones from Anemarrhena asphodeloides Bge. Exhibit Anticancer Activity in HepG2 Cells via the NF-κB Signaling Pathway. Molecules 2019; 24(12): 2246 doi: 10.3390/molecules24122246
|
| 157 |
Xu Yao, Chen-ru Zhao, Hao Yin, KeWei Wang, Jian-jun Gao. Synergistic antitumor activity of sorafenib and artesunate in hepatocellular carcinoma cells. Acta Pharmacologica Sinica 2020; 41(12): 1609 doi: 10.1038/s41401-020-0395-5
|
| 158 |
Cyriac A Philips, Sasidharan Rajesh, Dinu C Nair, Rizwan Ahamed, Jinsha K Abduljaleel, Philip Augustine. Hepatocellular Carcinoma in 2021: An Exhaustive Update. Cureus 2021; doi: 10.7759/cureus.19274
|
| 159 |
Qianhui Chen, Xinyu Lu, Jiayi Xie, Na Ma, Weikang Xu, Zhiming Zhang, Xuan Huang, Hongyan Liu, Jinlin Hou, Xiaoyong Zhang, Wei Zhu. Analysis of L Antigen Family Member 3 as a Potential Biomarker and Therapeutic Target Associated With the Progression of Hepatocellular Carcinoma. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.813275
|
| 160 |
Wen-Lung Su, Shih-Chang Chuang, Yu-Chu Wang, Lin-An Chen, Jian-Wei Huang, Wen-Tsan Chang, Shen-Nien Wang, King-Teh Lee, Chang-Shen Lin, Kung-Kai Kuo. Expression of FOXM1 and Aurora-A predicts prognosis and sorafenib efficacy in patients with hepatocellular carcinoma. Cancer Biomarkers 2020; 28(3): 341 doi: 10.3233/CBM-190507
|
| 161 |
Waleed El-Agawy, Sara Ahmed El-Ganainy, Magdy Abd Almawgoud Gad, Sherief Abd-Elsalam, Wessam Abd Alltaif Mostafa, Mohammed El-Sayed El-Shewi. Combined Transarterial Chemoembolization with Microwave Ablation
versus Microwave Alone for Treatment of Medium Sized Hepatocellular
Carcinoma. Current Cancer Drug Targets 2022; 22(1): 77 doi: 10.2174/1568009622666220117094146
|
| 162 |
Feng Duan, Jing Yuan, Xuan Liu, Li Cui, Yan-Hua Bai, Xiao-Hui Li, Huang-Rong Xu, Chen-Yang Liu, Wei-Xing Yu. Feasibility of hyperspectral analysis for discrimination of rabbit liver VX2 tumor. World Journal of Gastrointestinal Oncology 2019; 11(1): 1-8 doi: 10.4251/wjgo.v11.i1.1
|
| 163 |
Vahid Mansouri, Nima Rezaei. Hepatobiliary Cancers: An Interdisciplinary Approach. Interdisciplinary Cancer Research 2022; 3: 1 doi: 10.1007/16833_2022_70
|
| 164 |
Qiqi Tao, Zhichao Lang, Yifei Li, Yuxiang Gao, Lifan Lin, Zhengping Yu, Jianjian Zheng, Suhui Yu. Exploration and validation of a novel signature of seven necroptosis-related genes to improve the clinical outcome of hepatocellular carcinoma. BMC Cancer 2023; 23(1) doi: 10.1186/s12885-023-11521-x
|
| 165 |
Jānis Vilmanis, Ieva Strēle, Arturs Ozoliņš, Edvīns Miklaševičs, Jānis Gardovskis. Epidemiology of Hepatocellular Carcinoma in Latvia from 1997 to 2017. Proceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences. 2022; 76(2): 246 doi: 10.2478/prolas-2022-0037
|
| 166 |
Haohao Lu, Bin Liang, Xiangwen Xia, Chuansheng Zheng. Efficacy Analysis of PTCD + TACE vs PTCD + Apatinib in the Treatment of HCC with Obstructive Jaundice: A Retrospective Study. Anti-Cancer Agents in Medicinal Chemistry 2024; 24(17): 1241 doi: 10.2174/0118715206313132240712101607
|
| 167 |
Huijie Zhao, Yanting Zhang, Xiaodi Fu, Chaoren Chen, Saadullah Khattak, Honggang Wang. The double-edged sword role of hydrogen sulfide in hepatocellular carcinoma. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1280308
|
| 168 |
Dimitrios Moris, Brian I. Shaw, Lisa McElroy, Andrew S. Barbas. Using Hepatocellular Carcinoma Tumor Burden Score to Stratify Prognosis after Liver Transplantation. Cancers 2020; 12(11): 3372 doi: 10.3390/cancers12113372
|
| 169 |
Luzie A. Doemel, Julius Chapiro, Fabian Laage Gaupp, Lynn Jeanette Savic, Ahmet S. Kucukkaya, Alexandra Petukhova, Jonathan Tefera, Tal Zeevi, MingDe Lin, Todd Schlachter, Ariel Jaffe, Mario Strazzabosco, Timil Patel, Stacey M. Stein. Reliable prediction of survival in advanced-stage hepatocellular carcinoma treated with sorafenib: comparing 1D and 3D quantitative tumor response criteria on MRI. European Radiology 2021; 31(5): 2737 doi: 10.1007/s00330-020-07381-9
|
| 170 |
Shen Shen, Yanfang Wang. Expression and Prognostic Role of E2F2 in Hepatocellular Carcinoma. International Journal of General Medicine 2021; : 8463 doi: 10.2147/IJGM.S334033
|
| 171 |
Kaio Murilo Monteiro Espíndola, Roseane Guimarães Ferreira, Luis Eduardo Mosquera Narvaez, Amanda Caroline Rocha Silva Rosario, Agnes Hanna Machado da Silva, Ana Gabrielle Bispo Silva, Ana Paula Oliveira Vieira, Marta Chagas Monteiro. Chemical and Pharmacological Aspects of Caffeic Acid and Its Activity in Hepatocarcinoma. Frontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.00541
|
| 172 |
Qiang Tang, Shurui Wang, Huimin Li, Junzhi Liu, Xin Hu, Dong Zhao, Maojun Di. Integrated multi-omics analyses reveal the TM4SF family genes with prognostic and therapeutic relevance in hepatocellular carcinoma. Aging 2024; doi: 10.18632/aging.205398
|
| 173 |
Yang Liu, Heng Yang, Qiang Guo, Tingting Liu, Yong Jiang, Mingbo Zhao, Kewu Zeng, Pengfei Tu. Cucurbitacin E Inhibits Huh7 Hepatoma Carcinoma Cell Proliferation and Metastasis via Suppressing MAPKs and JAK/STAT3 Pathways. Molecules 2020; 25(3): 560 doi: 10.3390/molecules25030560
|
| 174 |
Dong-Jun Son, Ji-Yun Hong, Ki-Hyun Kim, Young-Hoon Jeong, Dae-Seong Myung, Sung-Bum Cho, Wan-Sik Lee, Yang-Jun Kang, Jin-Woong Kim, Young-Eun Joo. Liver abscess caused by Clostridium haemolyticum infection after transarterial chemoembolization for hepatocellular carcinoma. Medicine 2018; 97(19): e0688 doi: 10.1097/MD.0000000000010688
|
| 175 |
Roopali Roy, Emily Man, Rama Aldakhlallah, Emma Rashes, Marsha A. Moses. Biomarkers of the Tumor Microenvironment. 2022; : 379 doi: 10.1007/978-3-030-98950-7_22
|
| 176 |
Yanting Xie, Yizhou Wang, Renyan Gong, Jianbo Lin, Xifeng Li, Junyong Ma, Lei Huo. SNHG7 Facilitates Hepatocellular Carcinoma Occurrence by Sequestering miR-9-5p to Upregulate CNNM1 Expression. Cancer Biotherapy and Radiopharmaceuticals 2020; 35(10): 731 doi: 10.1089/cbr.2019.2996
|
| 177 |
Xue-Qin Li, Xing Wang, Da-Wei Zhao, Jun Sun, Jiao-Jiao Liu, Dong-Dong Lin, Guang Yang, Hui Liu, Zhen-Ying Xia, Cui-Yu Jia, Hong-Jun Li. Application of Gd-EOB-DTPA-enhanced magnetic resonance imaging (MRI) in hepatocellular carcinoma. World Journal of Surgical Oncology 2020; 18(1) doi: 10.1186/s12957-020-01996-4
|
| 178 |
NesreenG Elhelbawy, ManalA Safan, MostafaG Elhelbawy, BasmaA Mostafa, NohaR Bayomy. Metastasis-associated lung adenocarcinoma transcript 1 gene polymorphism in Egyptian patients with hepatocellular carcinoma. Menoufia Medical Journal 2022; 35(4): 1625 doi: 10.4103/mmj.mmj_200_22
|
| 179 |
Rabea Sobirey, Nickolai Matuschewski, Moritz Gross, MingDe Lin, Tabea Kao, Victor Kasolowsky, Mario Strazzabosco, Stacey Stein, Lynn Jeanette Savic, Bernhard Gebauer, Ariel Jaffe, James Duncan, David C. Madoff, Julius Chapiro. Tumor response assessment in hepatocellular carcinoma treated with immunotherapy: imaging biomarkers for clinical decision-making. European Radiology 2024; doi: 10.1007/s00330-024-10955-6
|
| 180 |
Ziwei Yuan, Xuejia Yang, Zujian Hu, Yuanyuan Gao, Penghua Yan, Fan Zheng, Yangyang Guo, Xiaowu Wang, Jingzong Zhou. Characterization of a predictive signature for tumor microenvironment and immunotherapy response in hepatocellular carcinoma involving neutrophil extracellular traps. Heliyon 2024; 10(10): e30827 doi: 10.1016/j.heliyon.2024.e30827
|
| 181 |
Mohammad Imran, Gowru Srivani, Ganji Seeta Rama Raju. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 3. 2022; : 197 doi: 10.1016/B978-0-323-99283-1.00026-4
|
| 182 |
Chao Chen, Yaohui Wang, Guodong Li, Lichao Xu, Ying Wang, Haozhe Huang, Biao Wang, Wentao Li, Xinhong He. Feasibility of CT-CT fusion imaging for evaluation of the cryoablation margins in visible hepatocellular carcinoma on unenhanced CT images: Initial experience. Journal of Interventional Medicine 2019; 2(2): 60 doi: 10.1016/j.jimed.2019.09.003
|
| 183 |
Wan Sun, Changchang Hu, Tianyu Wang, Juan Wang, Jieping Zhang, Furong Gao, Qingjian Ou, Haibin Tian, Caixia Jin, Jingying Xu, Jingfa Zhang, Guo-Tong Xu, Lixia Lu. Glia Maturation Factor Beta as a Novel Biomarker and Therapeutic Target for Hepatocellular Carcinoma. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.744331
|
| 184 |
Pedro Molina-Sánchez, Amaia Lujambio. Hepatocellular Carcinoma. Molecular and Translational Medicine 2019; : 333 doi: 10.1007/978-3-030-21540-8_16
|
| 185 |
Wafaa Mansour, Manal Kamel, Emad Elzayat, Shimaa Atta, Dalia Mahmood, Hanaa Abd El Fattah El Sayed, Taghreed Hussein, Sara Saber. Therapeutic Role of Bone Marrow-Derived Mesenchymal Stem Cells in Controlling Prognosis of Hepatocellular Carcinoma in a Murine Model. Experimental and Clinical Transplantation 2022; 20(1): 62 doi: 10.6002/ect.2020.0495
|
| 186 |
Zuhua Li, Ye Zhou, Guohua Yang, Siying He, Xueping Qiu, Lei Zhang, Qianyun Deng, Fang Zheng. Using circular RNA SMARCA5 as a potential novel biomarker for hepatocellular carcinoma. Clinica Chimica Acta 2019; 492: 37 doi: 10.1016/j.cca.2019.02.001
|
| 187 |
Ángel M. Cuesta, Nerea Palao, Paloma Bragado, Alvaro Gutierrez-Uzquiza, Blanca Herrera, Aránzazu Sánchez, Almudena Porras. New and Old Key Players in Liver Cancer. International Journal of Molecular Sciences 2023; 24(24): 17152 doi: 10.3390/ijms242417152
|
| 188 |
Krzysztof Bartnik, Joanna Podgórska, Grzegorz Rosiak, Krzysztof Korzeniowski, Jakub Giziński, Michał Sajdek, Tadeusz Wróblewski, Krzysztof Zieniewicz, Paweł Nyckowski, Olgierd Rowiński. Performance of initial LI-RADS 2018 treatment response in predicting survival of patients with hepatocellular carcinoma following TACE: a retrospective, single-center cohort study. Journal of Cancer Research and Clinical Oncology 2021; 147(12): 3673 doi: 10.1007/s00432-021-03603-9
|
| 189 |
Christina Liava, Emmanouil Sinakos, Elissavet Papadopoulou, Lamprini Giannakopoulou, Stamatia Potsi, Anestis Moumtzouoglou, Anthi Chatziioannou, Loukas Stergioulas, Lydia Kalogeropoulou, Ioannis Dedes, Evangelos Akriviadis, Danai Chourmouzi. Liver Imaging Reporting and Data System criteria for the diagnosis of hepatocellular carcinoma in clinical practice: A pictorial minireview. World Journal of Gastroenterology 2022; 28(32): 4540-4556 doi: 10.3748/wjg.v28.i32.4540
|
| 190 |
HepG2 Attenuation Induced by RNase A Modulates Gene Profiling and Immunophenotypic Characterization of Some Immune Cells Operating in Cancer Vaccine . Journal of Cancer Research Updates 2018; 7(1): 27 doi: 10.6000/1929-2279.2018.07.01.3
|
| 191 |
Federica De Muzio, Francesca Grassi, Federica Dell’Aversana, Roberta Fusco, Ginevra Danti, Federica Flammia, Giuditta Chiti, Tommaso Valeri, Andrea Agostini, Pierpaolo Palumbo, Federico Bruno, Carmen Cutolo, Roberta Grassi, Igino Simonetti, Andrea Giovagnoni, Vittorio Miele, Antonio Barile, Vincenza Granata. A Narrative Review on LI-RADS Algorithm in Liver Tumors: Prospects and Pitfalls. Diagnostics 2022; 12(7): 1655 doi: 10.3390/diagnostics12071655
|
| 192 |
Ana Paula Pagano, Juliana Maria Faccioli Sicchieri, Alexandre Souto de Moraes Morgado, Luiz Fernando Meira Filho, Maria Cristina Gonzalez, Carla M. Prado, Jorge Elias Junior, Andreza Correa Teixeira, Paula Garcia Chiarello. Phase Angle but Not Psoas Muscle Predicts Nutritional Risk and Prognosis in Males with Hepatocellular Carcinoma. Nutrition and Cancer 2024; 76(10): 963 doi: 10.1080/01635581.2024.2378504
|
| 193 |
Bin Sun, Dong Yang, Hongjiu Dai, Xiuyun Liu, Ru Jia, Xiaoyue Cui, Wenxuan Li, Changchun Cai, Jianming Xu, Xudong Zhao. Eradication of Hepatocellular Carcinoma by NKG2D-Based CAR-T Cells. Cancer Immunology Research 2019; 7(11): 1813 doi: 10.1158/2326-6066.CIR-19-0026
|
| 194 |
Yan-Li Zhu, Zhen-Qiang Wang, Xiang-Ming Wang. Relationship between MRI delayed enhancement of primary hepatocellular carcinoma and distribution of different fibrous components in pathological tissues. World Chinese Journal of Digestology 2019; 27(19): 1225 doi: 10.11569/wcjd.v27.i19.1225
|
| 195 |
Hantao Xue, Liya Qin, Longxiang Zhang, Xiaocheng Li, Fei Wu, Weiyu Wang, Chen Wang, Wenbin Diao, Bin Jiang, Bo Lian, Jingliang Wu, Jingkun Bai, Tongyi Sun, Chunling Zhao, Meihua Qu, Wenjing Yu, Yubing Wang, Zhiqin Gao. Preparation of docetaxel‑loaded, glycyrrhetinic acid‑modified nanoparticles and their liver‑targeting and antitumor activity. Experimental and Therapeutic Medicine 2021; 22(4) doi: 10.3892/etm.2021.10578
|
| 196 |
Upkar S. Gill, Patrick T. F. Kennedy. The impact of currently licensed therapies on viral and immune responses in chronic hepatitis B: Considerations for future novel therapeutics. Journal of Viral Hepatitis 2019; 26(1): 4 doi: 10.1111/jvh.13040
|
| 197 |
Jia-jia Lv, Wen-ting Song, Xin-min Li, Jian-mei Gao, Ze-li Yuan. Synthesis of a New Phenyl Chlormethine-Quinazoline Derivative, a Potential Anti-Cancer Agent, Induced Apoptosis in Hepatocellular Carcinoma Through Mediating Sirt1/Caspase 3 Signaling Pathway. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.00911
|
| 198 |
A.N. Katrich, A.N. Petrovskiy, N.A. Katrich, V.A. Porkhanov. Ultrasound in a differentiated treatment approach for liver diseases. Khirurgiya. Zhurnal im. N.I. Pirogova 2021; (12): 34 doi: 10.17116/hirurgia202112134
|
| 199 |
Yan Su, Ruizhu Xie, Qinyan Xu. LncRNA THAP9-AS1 highly expressed in tissues of hepatocellular carcinoma and accelerates tumor cell proliferation. Clinics and Research in Hepatology and Gastroenterology 2022; 46(10): 102025 doi: 10.1016/j.clinre.2022.102025
|
| 200 |
M A Osadchuk, A A Svistunov, E D Mironova, I N Vasil’eva, N V Kireeva. Diseases of biliary tract in the context of association with oncological diseases of the digestive system. Terapevticheskii arkhiv 2019; 91(12): 98 doi: 10.26442/00403660.2019.12.000455
|
| 201 |
Fei Chen, Fei Wang, Si Sun, Mei Zhu, Zheng Liu. Size measurements of hepatocellular carcinoma: comparisons between contrast and two-dimensional ultrasound. BMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-01535-1
|
| 202 |
Eshani J. Choksi, Mohammad Elsayed, Nima Kokabi. Antitumor Activity of Metformin Combined with Locoregional Therapy for Liver Cancer: Evidence and Future Directions. Cancers 2023; 15(18): 4538 doi: 10.3390/cancers15184538
|
| 203 |
Sen Wang, Geng Chen, Xiao Lin, Xiaohua Xing, Zhixiong Cai, Xiaolong Liu, Jingfeng Liu. Role of exosomes in hepatocellular carcinoma cell mobility alteration. Oncology Letters 2017; doi: 10.3892/ol.2017.7257
|
| 204 |
Li Song, Xiangzheng Su, Yao Lu, Dongliang Hua, Ziren Gao, Jinghua Pan. An Inflammation-Associated Prognosis Model for Hepatocellular Carcinoma Based on Adenylate Uridylate- (AU-) Rich Element Genes. Mediators of Inflammation 2023; 2023: 1 doi: 10.1155/2023/2613492
|
| 205 |
I. Mirón Fernández, F.J. León Díaz, J. Sánchez Segura, B. Sánchez Pérez, J.A. Pérez Daga, J.L. Fernández Aguilar, M.C. Montiel Casado, J. Santoyo Santoyo. Comparison of 3 Explant-Based Prognostic Models as Predictors of Hepatocellular Carcinoma Recurrence After Liver Transplantation: Analysis of Our Experience. Transplantation Proceedings 2019; 51(1): 80 doi: 10.1016/j.transproceed.2018.03.132
|
| 206 |
Yanling Bai, Zhigang Zheng, Mingmei Du, Hongwu Yao, Yunxi Liu, Jijiang Suo. Bloodstream Infection and Its Clinical Characteristics and Relevant Factors Associated with Interventional Therapy in a Large Tertiary Hospital: A Six Years Surveillance Study. BioMed Research International 2019; 2019: 1 doi: 10.1155/2019/8190475
|
| 207 |
Said A. Al-Busafi, Khalid AlNaamani. Liver Cancer in the Middle East. 2021; : 259 doi: 10.1007/978-3-030-78737-0_17
|
| 208 |
Anh Le Tuan Nguyen, Lei Si, John S Lubel, Nicholas Shackel, Kwang Chien Yee, Mark Wilson, Jane Bradshaw, Kerry Hardy, Andrew John Palmer, Christopher Leigh Blizzard, Barbara de Graaff. Hepatocellular carcinoma surveillance based on the Australian Consensus Guidelines: a health economic modelling study. BMC Health Services Research 2023; 23(1) doi: 10.1186/s12913-023-09360-4
|
| 209 |
Matteo Renzulli, Francesco Tovoli, Alfredo Clemente, Anna Maria Ierardi, Irene Pettinari, Giuliano Peta, Giovanni Marasco, Davide Festi, Fabio Piscaglia, Salvatore Cappabianca, Gianpaolo Carrafiello, Rita Golfieri. Ablation for hepatocellular carcinoma: beyond the standard indications. Medical Oncology 2020; 37(4) doi: 10.1007/s12032-020-01348-y
|
| 210 |
Juan Wang, Pengpeng Zhang, Juan Liao, Yan Zhu, Xiaoli Liu, Hong Tang. Association of α-fetoprotein levels with liver stiffness measurement in outpatients with chronic hepatitis B. Bioscience Reports 2021; 41(1) doi: 10.1042/BSR20203048
|
| 211 |
Armeen Mahvash, Steven Chartier, Mark Turco, Paula Habib, Steven Griffith, Scott Brown, S. Cheenu Kappadath. A prospective, multicenter, open-label, single-arm clinical trial design to evaluate the safety and efficacy of 90Y resin microspheres for the treatment of unresectable HCC: the DOORwaY90 (Duration Of Objective Response with arterial Ytrrium-90) study. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02204-1
|
| 212 |
Olorunseun O Ogunwobi, Trisheena Harricharran, Jeannette Huaman, Anna Galuza, Oluwatoyin Odumuwagun, Yin Tan, Grace X Ma, Minhhuyen T Nguyen. Mechanisms of hepatocellular carcinoma progression. World Journal of Gastroenterology 2019; 25(19): 2279-2293 doi: 10.3748/wjg.v25.i19.2279
|
| 213 |
Ying Yang, Feng-Ping Wu, Wen-Jun Wang, Juan-Juan Shi, Ya-Ping Li, Xin Zhang, Shuang-Suo Dang. Real life efficacy and safety of direct-acting antiviral therapy for treatment of patients infected with hepatitis C virus genotypes 1, 2 and 3 in northwest China. World Journal of Gastroenterology 2019; 25(44): 6551-6560 doi: 10.3748/wjg.v25.i44.6551
|
| 214 |
Advanced therapeutics avenues in hepatocellular carcinoma: a novel paradigm. Medical Oncology 2023; 40(8) doi: 10.1007/s12032-023-02104-8
|
| 215 |
M. Ghosn, H. Derbel, R. Kharrat, N. Oubaya, S. Mulé, J. Chalaye, H. Regnault, G. Amaddeo, E. Itti, A. Luciani, H. Kobeiter, V. Tacher. Prediction of overall survival in patients with hepatocellular carcinoma treated with Y-90 radioembolization by imaging response criteria. Diagnostic and Interventional Imaging 2021; 102(1): 35 doi: 10.1016/j.diii.2020.09.004
|
| 216 |
Chintapanti Swetha, Bala Prabhakar Girish. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma. 2022; : 73 doi: 10.1016/B978-0-323-98806-3.00016-7
|
| 217 |
Emily A. Thompson, Megan C. Jacobsen, David T. Fuentes, Rick R. Layman, Erik N. K. Cressman. Quantitative dual‐energy computed tomography with cesium as a novel contrast agent for localization of thermochemical ablation in phantoms and ex vivo models. Medical Physics 2023; 50(12): 7879 doi: 10.1002/mp.16558
|